Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: a meta‐analysis

Z Yang, A Hackshaw, Q Feng, X Fu… - … journal of cancer, 2017 - Wiley Online Library
Gefitinib, erlotinib and afatinib are three widely used epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR TKIs) for treating advanced non‐small cell lung cancer …
被引用次数：211 相关文章

Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.

Z Yang, A Hackshaw, Q Feng, X Fu… - … Journal of Cancer, 2017 - europepmc.org
Gefitinib, erlotinib and afatinib are three widely used epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR TKIs) for treating advanced non-small cell lung cancer …

[引用][C] Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: A meta‐analysis

Z Yang, A Hackshaw, Q Feng, X Fu, Y Zhang… - International Journal of …, 2017 - cir.nii.ac.jp
Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: A meta‐analysis |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Comparison of gefitinib, erlotinib and afatinib in non‐small cell lung cancer: A meta‐analysis

Z Yang, A Hackshaw, Q Feng, X Fu, Y Zhang… - International Journal of …, 2017 - infona.pl
Gefitinib, erlotinib and afatinib are three widely used epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR TKIs) for treating advanced non‐small cell lung cancer …

Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis

Z Yang, A Hackshaw, Q Feng, X Fu… - … journal of cancer, 2017 - pubmed.ncbi.nlm.nih.gov
Gefitinib, erlotinib and afatinib are three widely used epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR TKIs) for treating advanced non-small cell lung cancer …

Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis

Z Yang, A Hackshaw, Q Feng, X Fu… - … Journal of Cancer, 2017 - discovery.ucl.ac.uk
Gefitinib, erlotinib and afatinib are three widely used epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR TKIs) for treating advanced non-small cell lung cancer …